Strategies to maintain sexual function post-treatment for prostate cancer

A research group at the University of Otago in New Zealand is continuing to investigate how men treated for prostate cancer deal with sexual dysfunction. We have helped them with this before and will continue to do so. … READ MORE …

Pembrolizumab in treatment of advanced prostate cancer

We finally have some published data — albeit not a lot — on the use of one of the PD-1 inhibitors (pembrolizumab, also known as Keytruda) in the treatment of late-stage prostate cancer. … READ MORE …

Promising new data on lutetium-177 PSMA radioligand therapy

According to a presentation given last week in San Francisco, lutetium-177 (177Lu) prostate-specific membrane antigen (PSMA) radioligand therapy has significant clinical activity in men with metastatic prostate cancer (as opposed to just in men with very late stages of prostate cancer). … READ MORE …

But can exercise lower risk for prostate cancer diagnosis or progression?

In an incidentally timely manner, the May issue of Annals of Oncology carries a systematic review and meta-analysis of data on physical activity and risk for prostate cancer. … READ MORE …

Physical activity and prostate cancer-specific survival times

Yet another study has confirmed the benefits of regular exercise in the prevention or delay of prostate cancer-specific mortality among men with non-metastatic prostate cancer. … READ MORE …

Anethole: might it be an effective prostate cancer drug?

We are well aware that many patients are interested in the potential of “natural products” as effective and safe forms of treatment for cancer. … READ MORE …

Physical activity and cancer recurrence: a detailed review

Readers with a strong interest in the relationships between exercise and risk for cancer recurrence may want to download and read the full text of a recent article by Friedenreich et al. … READ MORE …